Several previous studies have successfully inhibited the proliferation and invasion of various tumor cells, such as glioblastoma, lymphoma, ovarian cancer, and hepatocellular carcinoma cells, by inhibiting the TFRC gene (43–46). This evidence concerns the gene TFRC and neoplasm.